Communications Medicine (Nov 2022)
Correlation between structural heart disease and cardiac SARS-CoV-2 manifestations
- Felix Nägele,
- Michael Graber,
- Jakob Hirsch,
- Leo Pölzl,
- Sabina Sahanic,
- Manuel Fiegl,
- Dominik Hau,
- Clemens Engler,
- Sophia Lechner,
- Anna Katharina Stalder,
- Kirsten D. Mertz,
- Jasmin D. Haslbauer,
- Alexandar Tzankov,
- Michael Grimm,
- Ivan Tancevski,
- Johannes Holfeld,
- Can Gollmann-Tepeköylü
Affiliations
- Felix Nägele
- Department of Cardiac Surgery, Medical University of Innsbruck
- Michael Graber
- Department of Cardiac Surgery, Medical University of Innsbruck
- Jakob Hirsch
- Department of Cardiac Surgery, Medical University of Innsbruck
- Leo Pölzl
- Department of Cardiac Surgery, Medical University of Innsbruck
- Sabina Sahanic
- Department of Internal Medicine II, Medical University of Innsbruck
- Manuel Fiegl
- Department of Cardiac Surgery, Medical University of Innsbruck
- Dominik Hau
- Department of Cardiac Surgery, Medical University of Innsbruck
- Clemens Engler
- Department of Internal Medicine I, Medical University of Innsbruck
- Sophia Lechner
- Department of Cardiac Surgery, Medical University of Innsbruck
- Anna Katharina Stalder
- Institute of Medical Genetics and Pathology, University Hospital Basel
- Kirsten D. Mertz
- Institute of Pathology, Cantonal Hospital Baselland
- Jasmin D. Haslbauer
- Institute of Medical Genetics and Pathology, University Hospital Basel
- Alexandar Tzankov
- Institute of Medical Genetics and Pathology, University Hospital Basel
- Michael Grimm
- Department of Cardiac Surgery, Medical University of Innsbruck
- Ivan Tancevski
- Department of Internal Medicine II, Medical University of Innsbruck
- Johannes Holfeld
- Department of Cardiac Surgery, Medical University of Innsbruck
- Can Gollmann-Tepeköylü
- Department of Cardiac Surgery, Medical University of Innsbruck
- DOI
- https://doi.org/10.1038/s43856-022-00204-6
- Journal volume & issue
-
Vol. 2,
no. 1
pp. 1 – 8
Abstract
Nägele, Graber et al. evaluate cardiac manifestations of SARS-CoV-2 in patients with structural heart disease. The authors find that detection of SARS-CoV-2 in heart tissue is associated with poorer survival.
